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Communication of information about genetic risks: putting families at the centre 
  
ABSTRACT 
Genetic information is a family affair. With the expansion of genomic technologies, many 
new causal genes and variants have been established and the potential for molecular 
diagnoses increased, with implications not only for patients but also their relatives. The 
need for genetic counselling and intrafamilial circulation of information on genetic risks 
grew accordingly. Also, the amount and, particularly, the complexity of the information to 
convey multiplied. Sharing information about genetic risks with family members, however, 
has never been an easy matter and often becomes a source of personal and familial 
conflicts and distress. Ethical requisites generally prevent healthcare professionals from 
directly contacting their consultands’ relatives (affected or still at-risk), who often feel 
unsupported throughout that process.  
We discuss here the communication of genetic risks to family members. We first consider 
genomic testing as a basis for family-centred health care, as opposed to a predominant 
focus on the individual. We reviewed the literature on sharing genetic risk information with 
family members, and the associated ethical issues for professionals. Some clinical cases 
are presented and discussed, and key issues for meeting the needs of individuals and 
families are addressed. We argue that genetic information is inextricably linked to the 
family, and that communicating about genetic risks is a process grounded within the 
broader milieu of family relationships and functioning. We conclude for the need for a more 
family-centred approach and interventions that can promote sensitive attitudes to the 
provision of genetic information to and within the family, as well as its inclusion in 
educational and training programmes for genetic healthcare professionals. 
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INTRODUCTION 
Genomic technologies offer a great potential for improved diagnosis, treatment and 
prevention for a growing number of genetic diseases. As genome-based testing (multigene 
panels, whole-exome or whole-genome sequencing) becomes routine, the number of 
persons known to be affected or at-risk for inherited conditions increases. Genetic testing 
and genetic information (Sequeiros et al, 2012) have implications not just for the individual, 
but also their relatives. This often becomes a challenge, as families may feel unsure about 
that information, and how, when and whom to tell (Gaff & Byllund, 2010). Genetics health 
professionals (GHPs) and services are thus confronted with the need not just to provide 
care to the individuals tested, but also to help families understand and cope with genetic 
information (McDaniel, Rolland, Feetham, & Miller, 2006; Rolland, 1999).  
Whilst many scholars and clinicians have long claimed the importance of paying attention 
to family relationships in the dissemination of genetic information (Feetham, 1999; 
McDaniel, 2005; Peters, Djurdjinovic & Baker, 1999; Rolland, 2006a), existing literature 
mostly focuses on what prompts (or hinders) individual patients to disclose that information 
to their relatives (McClellan et al., 2013). This fails to acknowledge the intricacies of the 
communicative processes that operate within the family and how they are entwined with 
other domains of family functioning. Additionally, genetic health care is mainly designed to 
address individuals, and more family-centred approaches are still scarcely embedded into 
routine care, which may leave families ill-supported while they seek to integrate genetic 
information into their lives. 
In this article, we discuss the communication of genetic risks to family members. First, we 
set genetic knowledge as a basis for family-centred health care, as opposed to its 
predominant focus on the individual. Then, we present a systemic lens for understanding 
genetic diseases, based mostly on the Family Systems Genetic Illness (FSGI) model 
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(Rolland & Williams, 2005). Next, we discuss the sharing of genetic risk information within 
the family, including instructive clinical cases, and ethical dilemmas faced by GHPs. We 
address some of the key issues for meeting the needs of individuals and families; in doing 
so, we frame genetic information as a family affair and present communication about 
genetic risks as a process that encompasses and impacts the family all along. Finally, we 
highlight the need for family-centred care and interventions designed to help families 
managing genetic risk information, and a call is made for an appreciation of the family as 
the biopsychosocial unit of care. 
 
GENOMICS: ORIENTING CARE TO THE INDIVIDUAL OR TO THE FAMILY? 
Genetic information differs from most other disease-related information because of its 
familial character. Disclosure of genetic information to relatives gives them the opportunity 
to make informed choices regarding treatment, prevention or changes in life-styles. 
Depending on the type of disease (mode of inheritance and penetrance, age-at-onset, 
clinical severity and psychosocial burden, treatments available, and potential for early 
detection and follow-up) and its associated level of uncertainty, this may pose a difficult 
challenge. For example, knowing that an individual carries a mutation in BRCA1/2 (linked 
mainly to breast, ovarian and prostate cancer) will be relevant for biological relatives, who 
may or may not wish to consider genetic testing and appropriate preventive options, as 
well as reproductive and other life-planning choices. This intrafamilial communication, 
however, is not always straightforward, and consultands (whether already affected, 
presymptomatic carriers or still at-risk) often feel unsupported in managing it (Gaff et al., 
2007).  
Traditionally, there has been a great emphasis on individualized healthcare. The 
burgeoning precision medicine movement insinuates that genomics will tailor prediction, 
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diagnosis and treatment to every person (Tutton, 2012). In stark contrast with this 
dominating narrative, the converse is that genome-based tests have far greater 
implications for family relations than does directed, conventional genetic testing. 
Furthermore, genomic testing increases the need to involve family members to clarify 
incidental findings and inconclusive test results (newly-discovered variants and variants of 
unknown significance) (Hallowell, Hall, Alberg & Zimmern, 2015). This entails processing 
information and involvement across and within generations of a family. GHPs work mostly 
with individuals or nuclear families, and often have limited access to the wider family 
network. Help offered by these professionals is usually information-based and focuses 
predominantly on the individual, rather than the family unit (Mendes, Paneque, Sousa, 
Clarke & Sequeiros, 2016). GPHs also indicate they do not always address issues of 
family communication in their practice (Forrest, Delatycki, Curnow, Skene, & Aitken, 2010). 
Additionally, privacy requirements prevent healthcare professionals from directly informing 
their patient’s relatives (Parker, 2001). This can lead patients to feel frustrated, as they are 
given indications as to which relatives to inform, but often no support to proceed with doing 
so. How will families respond as more information is generated via genomic analysis? 
 
A family view on genetic illnesses 
The experience of a genetic illness in the family has been well described in the family-
systems literature (Brouwer-DudokdeWitt, Savenije, Zoeteweij, Maat-Kiewit & Tibben, 
2002; Kessler & Bloch, 1989; Sobel & Cowan, 2003). A conceptual framework setting out 
likely psychosocial demands of families with various genetic conditions was provided by 
Street & Soldan (1998). Based on Rolland’s Family Systems Illness (FSI) model (Rolland, 
1984), they proposed to expand the ‘illness stages’ to include the ‘pre-illness phase’. 
Subsequently, Rolland & Williams (2005) extended the earlier model to include genetic 
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disorders (the FSGI model), especially the presymptomatic phases of genetic diseases, 
aiming to understand their impact on the coping processes of family members. Coping with 
awareness of a possible genetic risk, consideration and active decision-making regarding 
testing, and the incorporation of genetics knowledge into personal and family life are 
important challenges.  
Developments in genetics increasingly blur the boundaries between health and illness, 
creating “patients in waiting” (Timmermans & Buchbinder, 2010). Living with uncertainty, 
the quantity of medical information presented, sharing risks with relatives and the 
psychosocial impact of those choices are other fundamental issues outlined in the FSGI 
model (Rolland & Williams, 2005). This includes a psychosocial typology, based on four 
biological variables: likelihood of developing the genetic condition (penetrance), clinical 
severity, age of onset, and availability of treatment or preventive measures. The FSGI 
model acknowledges the interface between temporal phases of a genetic condition 
through the individual and family life-cycle and the influence of anticipatory loss, i.e., living 
with possible, probable or inevitable future losses, after the diagnosis of a hereditary 
disease (Rolland, 1990; 2006b). Intergenerational effects have a greater impact with 
dominantly inherited or sex-linked disorders. In sum, this model suggests a framework to 
organize the complexity of genetics into a common meta-language, to help health 
practitioners viewing genetic diseases longitudinally, as an ongoing process, with 
transition points and changing demands. 
 
FROM THE CLINIC TO THE FAMILY: COMMUNICATING GENETIC RISK 
INFORMATION TO FAMILY MEMBERS 
Family issues that may arise from the communication of genetic information are commonly 
discussed in genetic counselling, including identification of at-risk relatives. Test results 
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are often given in person to the consultand. Traditionally, professionals rely on patients 
(or, if minors, their parents) to pass on that information to other family members, and 
reinforce the importance of this. However, consultands may feel unsure about the 
responsibility of professionals; some believe that professionals should be the ones to 
inform relatives rather than themselves (Mesters, Ausems, Eichhorn, & Vasen, 2005). The 
explicit refusal to share relevant information with relatives is rare (Clarke et al., 2005), but 
failure of communication may occur for many other reasons. For those requiring support or 
showing difficulties in this process, professionals may use multiple strategies, particularly 
psycho-educational guidance and written materials to be given to at-risk relatives (Mendes 
et al., 2016).  
 
Genetics healthcare professionals’ ethical dilemmas  
Ethical and professional guidelines advocate that professionals should not contact family 
members directly (Forrest, Delatycki, Skene & Aitken, 2007). Guidelines also state that 
professionals should encourage consultands to transmit risk information to relatives and 
support them throughout the communication process, although it is not clear how this 
should be done. Possible dilemmas involve the balance of the patient’s autonomy and 
right to privacy with potential for harm to relatives. Professionals’ responsibility and 
proactivity to ensure awareness of relatives about their risks have long been debated and 
still need further clarification (Clarke, 1997; Dheensa, Fenwick, Shkedi-Rafid, Crawford, & 
Lucassen, 2016). Some countries (e.g., Australia and France) bind patients to inform 
family members and provide professionals the right to override their patients’ 
confidentiality. 
Traditionally, biomedical models see patients as the “owners” of their personal medical 
information; however, genetic information is shared with blood relatives and thus 
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challenges the meaning of these assumptions (Widdows, 2013). Relational approaches to 
autonomy emphasize that it may be enhanced through solidarity, engagement and social 
embeddedness (Dove et al., 2017). For example, the joint account model conceptualizes 
clinical information as personal, but genetic information as “belonging” to all pertinent 
relatives; this way, disclosure of information within this circle would not represent a breach 
of confidentiality (Dheensa, Fenwick & Lucassen, 2016). Genetic information, however, is 
also viewed as ultimately private, and there are difficulties in clearly defining which 
relatives have equal right-of-access to it (Clarke, 2007), and whether and how they may 
preserve their right not-to-know (Chadwick, 2009).  
  
Sharing genetic risk information with family members 
Empirical research shows that, although consultands of genetics services (or their parents) 
are generally willing to transmit relevant information to their relatives, sharing genetic risk 
information with family members is sometimes problematic (Seymour Addington-Hall, 
Lucassen & Foster, 2010). Estimates suggest that only 15-20% at-risk relatives become 
aware of important information, and test uptake by relatives is generally low (Fehniger, Lin, 
Beattie, Joseph & Kaplan, 2013). Also, Daly and colleagues (2016) reported that 82% of 
the first-degree relatives to whom probands (the first in the family to get tested) had 
reported their test results for BRCA1/2 had correctly understood the results; nevertheless, 
their intention to pursue genetic testing was substantially lower. This, however, is just a 
proxy measure of family communication and depends also of other variables. Qualitative 
studies show that this transmission, itself, may be withheld, delayed or incomplete. Indeed, 
patients may have a poor understanding of it, or they may anticipate their family members 
would not want to know or are unable to understand or cope with it (Featherstone, 
Atkinson, Bharadwaj, & Clarke, 2006). 
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Family dynamics, including patterns of rules and boundaries, influence preferences about 
sharing and knowing health information within the family. This is impacted by the range of 
biological variables of the disease that are important in a clinical evaluation (Rolland & 
Williams, 2005). While some relatives act as proactive gatherers and disseminators of 
genetic information, others block the communication process (Kohely et al., 2009).  
Two anonymised examples, from real cases, are presented next to illustrate some of the 
relevant issues in sharing genetic information in families. 
 
Rita’s guilt: gathering extended family members for predictive testing 
In a family with Huntington disease (HD), Rita was the youngest and the only of three sisters not 
carrying an expanded HD gene. HD is a progressive, fatal neurodegenerative condition, with onset 
most often by age 35-60 years, with a a apriori 50% risk to sibs and offspring. It leads to involuntary 
movements (chorea), motor impairment, behavioural symptoms and cognitive decline. Her father had 
had the disease, as well as several of her uncles and aunts. Rita was 49 years-old at the time of 
presymptomatic testing; she has three adult sons and had divorced when they were young children. 
She had never kept a long-standing relationship thereafter and was living with her younger son. In a 
very enmeshed family, she structured her life as a caregiver for both her affected sisters, until they 
died. During genetic counselling, it became clear she was having difficulties dealing with her non-
carrier result and became severely depressed. She also developed a very strong sense of 
responsibility towards her seven nephews/nieces (all in their mid-to-late twenties), and was very 
proactive, even forceful, in trying to persuade and bring every single one of them for genetic testing.  
 
Genetic information has the potential for altering family relationships. As in this case, 
altruistic intentions and behaviours may emerge, as Rita experienced “well-sibling”, 
survivor guilt in relation to her sisters. This first became apparent as she assumed the role 
of caregiver for them, and, later on, when she made all efforts to bring her nephews/nieces 
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for presymptomatic testing. The testing experience can be most intense for support 
persons and may extend to subsequent caregiving responsibilities (Williams et al., 2000). 
Rita had difficulties finding a balance between relief (as a non-carrier) and the concern for 
her at-risk relatives, as if awareness of her risk-free future prompted a ruptured loyalty 
towards her family legacy of HD. Additionally, the pressure she exerted on her 
nephews/nieces potentially disturbed their own autonomous decision-making process for 
genetic testing and thus increased the risk for family conflicts. This underscores the 
importance of providing long-time engagement with families (including the extended 
family) and also with those who are non-carriers.  
Communication is one aspect of family processes that includes systems of belief and 
family organization, transgenerational patterns of coping and life-cycle challenges 
(McDaniel et al., 2006). These processes are embedded in the everyday reality of families, 
and the communicative style of the family reveals how family members manage closeness 
and distance while they deal with difficult topics, such as genetic risk, illness and 
healthcare (Atkinson, Featherstone, & Gregory, 2013; Featherstone et al., 2006; Forrest et 
al., 2003), including genetic testing. 
Cultural factors also shape family communication. Ethnicity and religion may lead some 
families and communities to feel more reluctant to generate and disclose risk information 
in the family, because of its potential negative impact on honour and marriage prospects 
(Shaw & Hurst, 2009). These decisions are also affected by concerns regarding privacy, 
stigmatization and discrimination (Mendes, Sousa, Sequeiros, & Clarke, 2017). Open 
communication allows family members to develop a shared understanding and support 
one another, becoming more likely to cope and adapt well to living with the genetic 
condition or its risk and establishing more resilient relations (Hoskins, Roy, Peters, Loud & 
Greene, 2008). Open communication tends to occur more frequently among women, first-
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degree relatives or spouses, while those under 18 years are less likely to be given 
information (Oliveira, Mendes, & Sousa, 2017; Van Oostrom et al., 2007). Approximately 
40% of parents do not talk to their children about their family’s condition, although most 
would like to be able to do so (Metcalfe, Coad, Plumridge, Gill & Farndon, 2008). 
Communication styles vary in a continuum ranging from disengaged to enmeshed patterns 
of communication, and can evolve over time as family members go through their life cycle 
(Brouwer-DudokdeWitt et al., 2002; McDaniel et al., 2006). For example, parents may 
decide not to inform their children about the genetic condition, as they lack confidence in 
deciding when and how to talk; they may change their mind as offspring approach 
adulthood and information can have implications for life planning, such as selecting 
partners and procreation. 
 
Eugénio’s burden with his ataxia test results 
Eugénio was aged 48 when his pre-symptomatic test for spinocerebellar ataxia type 2 (SCA2) showed 
him to carry his family’s disease mutation. As this is a fully-penetrant single-gene disorder, he is 
certain to develop it sometime in the future, but also that his 16 year-old son has a 50% risk of 
carrying it too. SCA2 is a late-onset, incurable neurological disease, progressing to severe motor 
impairment. Eugénio has two older brothers, both non-carriers. He has been aware of his risk since 
early adulthood, when his uncles became affected. He then decided to live a carefree life, without the 
burden of knowing his genetic status. After his mother became affected a few years ago, he began to 
actively consider being tested. As the bread-winner in a middle-class family, Eugénio has been 
running the family business for several years and fears having to stop this when symptoms become 
severe. He shared the test result with his wife, brothers and father. His brothers urged him to keep it a 
secret from their mother, in order to protect her from alarm and blame. Eugénio, himself, is reluctant to 
inform his son, as he fears the effects this might have on his wellbeing, while his wife thinks they 
should tell him. This disagreement intensified marital stress, and problems emerged when Eugénio 
started to show early symptoms of the disease. At this point, the couple was clearly having difficulties 
adapting to this new stage of their lives together. 
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This case highlights how the sharing of genetic information can be affected by secrecy in 
the family system. In this case, Eugénio seem to accept family values around genetic 
knowledge through alignment with his siblings, though colliding with how his spouse 
prefers to manage it with their son. This case also illustrates how predictive testing, as well 
as chronic illness, can impact on the balance of partner relationships. Indeed, couples may 
have to deal with issues of anticipatory loss, as test results challenge their expectations 
about the future (Rolland, 1999). This includes rescheduling joint life-planning, as well as 
optimising the timescale for passing information about risk to their children. The crisis 
arising at the transition to overt disease is a further burden to the family system. This case 
underscores the relevance of pre- and post-test family consultations, exploring the 
implications of secrecy, as well as the right of access to information, and providing ongoing 
support to the family system.  
 
HOW TO MEET THE NEEDS OF INDIVIDUALS AND FAMILIES? 
Genetics services have traditionally emphasised the need to prepare a person for genetic 
testing and its results, but have placed less emphasis on the secondary impact on other 
members of the family. Indeed, the reflective process commonly used by professionals 
when supporting consultands through predictive testing will not always address the 
communication processes operating within the family. Consistent with this, interventions 
aimed at facilitating communication to relatives are mainly centred on the need of the 
patient to disclose information about him/herself, so that relatives may come to know their 
own risks (Mendes et al., 2016). Information is typically delivered as a single transaction, 
often in a transmitter-receiver fashion, highlighting what is communicated and with whom. 
In general, research focuses on the “disclosure” of test results to at-risk relatives and how 
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this is recalled. These simplistic models of communication regard individuals as equals, 
who are well placed to absorb what they are told, and treat information as something that 
can be passed, unaltered, from person to person in the family.   
However, disclosing genetic risks is more than the transmission of discrete parcels of 
‘information’. It goes beyond the consultand’s motivations regarding “disclosure” and the 
actions promoted by professionals to improve dissemination of information. In fact, tension 
may arise in families when professionals use heavy-handed prompts to encourage it 
(Carrieri, Farrimond, Kelly & Turnpenny, 2016). Concern for the continuity of family life 
may lead some to avoid the potential disruption caused by transmission of genetic risk 
information and, thus, families may choose to act in ways at odds with medical advice 
(Geelen, Van Hoyweghen & Horstman, 2011).  
 
Using multifamily discussion groups (MFDGs) to support families 
Systemic family-centred approaches have a long tradition in assisting families to deal with 
complex biomedical situations, often more clinically effective and cost-efficient than 
individually-based care (Weihs et al., 2002; Proulx & Snyder, 2009). Two groups, in 
Portugal and the UK, have independently begun developing a more systemic approach to 
family care for those affected by genetic diseases, particularly using psycho-educational 
MFDGs: these have been established as family-centred interventions for chronic medical 
illnesses (Steinglass, 1998; Steinglass et al., 2011); pilot MFDGs have been implemented 
as a way of promoting families’ adaptation to cancer genetic risks (Mendes, Chiquelho, 
Santos & Sousa, 2010; 2015), and also to facilitate family communication about a range of 
genetic conditions (SPRinG, 2016a). Families participated in creative and experiential 
exercises about building a sense of identity, belonging and self-esteem. Preliminary 
evaluations suggest a therapeutical effect; families reportedly find MFDGs highly beneficial 
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in facilitating bonding and extra-familial networks, and improving psychological wellbeing 
(SPRinG, 2016a; Mendes et al., 2010; 2015). MFDGs educated family members about the 
genetic disease and facilitated families talking to and learning from each other about it, 
while coping with and adapting to its impact.  
A UK team also began investigating the possibility of training genetic counsellors and 
nurses to deliver this intervention (SPRinG, 2016b). This training took longer than 
anticipated; although they consider their work to be family-centred, they are not trained in 
family evaluation and interventions. This is a shortcoming in educational programmes for 
genetic healthcare professionals that should be considered when designing them.  
 
TOWARDS A FAMILY-CENTRED APPROACH? 
Communicating about genetic risks to and within the family is a longitudinal process. It 
challenges traditionally established assumptions about the belonging of medical 
information and right-of-access to it, and may depend on local legislation and professional 
guidelines. A systemic, family-centred approach can enhance the understanding of this 
processes of communication and the care of those involved. This requires more training 
for GHPs in family systems evaluation and consultation (e.g. family assessment and 
interpersonal counselling skills), so they may feel more confident in working in the context 
of families and running family-centred interventions such as MFDGs. 
Medical family therapy (MFT) has long provided a suitable framework for family-centred 
health care (McDaniel, Doherty, & Hepworth, 1992). The inclusion of professionals trained 
in MFT in genetics services has been suggested (Feetham, 1999; McDaniel, 2005). Its 
applications may also include the supervision of practitioners and interdisciplinary 
collaboration, and the training of professionals to bridge specific gaps in the care of 
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patients and their families. Besides MFDGs, family consultations, couple and family 
therapy, and individual or group psycho-education are other interventions that might 
enable genetics services to engage with consultand’s strengths and vulnerabilities and key 
relationships (McDaniel et al., 2006).  
Longitudinal family systems consultations, before and after testing, may help identifying 
core aspects of family functioning with a genetic disease, including processes of 
communication. Of course, involvement of extended family members should not pre-empt 
individual autonomy. To include everyone who might be relevant denies the consultand 
the opportunity to keep any secrets at all, so that the question of disclosing or not an 
information item never arises, as it will have already been disclosed. A space needs to be 
designed, within which these considerations can be articulated and weighed.  
Careful consideration is needed about who in the family would be relevant for discussions 
around privacy, secrecy and “responsible” communication about genetic risks. This 
includes nuclear and extended family members, as well as non-biological relatives and not 
only those at-risk or with carrier test results (Rolland, 1999). However, GHPs may have 
only limited access to the wider family network. They need to promote the consultand’s 
adjustment, while gaining insight into processes of communication within families and its 
potential consequences for the consultands. This exploration should contribute to the 
consultand to consider his/her options and preferences, and to anticipate management of 
challenges and concerns underlying genetic/genomic information. Additionally, it could 
help building a comprehensive plan to support planning communication with family 
members. 
 
CONCLUSION 
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We consider the process of communicating information about a genetic disease and 
associated risks as a family affair. We discussed difficulties families face when sharing 
information with relatives and acknowledged practical and ethical issues commonly met by 
GHPs. We then reflected on how current clinical ethics standards may not be completely 
apt for genetics/genomics information, and questioned efficacy of intra-familial 
communication. Finally, we introduced MFDGs as an example of systemic-inspired 
interventions to help families effectively communicating genetic information to relatives, 
and reflected on the need for family-centred care in genetics healthcare services.  
Whereas GHPs have always emphasized the shared nature of genetic information, 
including preparing consultands to convey that information within the family, far less 
attention is generally paid to supporting them in that process. Family systems interventions 
could be seen as a natural approach to be adopted towards family-centred care. This 
could facilitate handling of genetic information within the family, minding the need to avoid 
“one-size-fits-all” solutions and to acknowledge the complexity and plurality of family life. 
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